Teri Longacre, M.D. Professor of Pathology; Director of Gastrointestinal Pathology; Director of Stanford Tissue Procurement Facility, Department of Pathology.

Research Description: Dr. Longacre has focused research on gastrointestinal and gynecologic cancers – including hereditary cancer syndromes. In addition to her own research, she has spent her career as a surgical oncologic pathologist, actively collaborating with surgeons, oncologists, and gastroenterologists in the development of new techniques in screening and treating cancer patients. She has collaborated with several basic research, surgical, oncologic colleagues at Stanford to improve our diagnosis, treatment, and overall understanding of pancreatic cancer. Her knowledge of the pathology of gastrointestinal cancer in conjunction with directorship of the Stanford Cancer Center Tissue Procurement Facility are particularly well suited to the mission of the Stanford PCRG.

Dr. Longacre collaborates with PCRG members including Drs. Aida Habtezion, Seung Kim, Walter Park, Brendan Visser, Laura Attardi, Daniel Chang, George Fisher, Jim Ford, Sam Gambhir, Amato, Giaccia. Hanlee Ji, George Poultsides, and Jeanne Shen.

Selected relevant publications (Stanford PCRG members in bold):

  1. Tummers WS, Miller SE, Teraphongphom NT, Gomez A, Steinberg I, Huland DM, Hong S, Kothapalli SR, Hasan A, Ertsey R, Bonsing BA, Vahrmeijer AL, Swijnenburg RJ, Longacre TA, Fisher G, Gambhir SS, Poultsides GA, Rosenthal EL. Intraoperative pancreatic cancer detection using multimodality molecular imaging. Ann Surg Oncol, In Press.

  2. Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, Bieging-Rolett KT, Lee J, Ivanochko D, Kozak MM, Chang DT, Longacre TA, Koong AC, Arrowsmith CH, Kim SK, Vogel H, Wood LD, Hruban RH, Curtis C. Attardi LD. A p53 super-tumor suppressor reveals a tumor suppressive p53-Ptpn14-Yap axis in pancreatic cancer. Cancer Cell, In Press

  3. Lee J, Snyder ER, Liu Y, Gu X, Wang J, Flowers BM, Kim YJ, Park S, Longacre TA, Szot GL, Hruban RH, Kim SK. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells. Nat Commun. 2017 Mar 8;8:14686. doi: 10.1038/ncomms14686

  4. Kidess-Sigal E, Liu H, Triboulet M, Che J, Ramani V, Visser B, Poultsides G, Longacre T, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, Keilholz U, Tinhofer-Keilholz I, Norton J, Lee M, Sollier-Christen E, Jeffrey S. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: comparison to ctDNA and tissue in metastatic colorectal cancer. Oncotarget. 2016 Dec 20;7(51):85349-85364. doi: 10.18632/oncotarget.13350

  5. Schaberg KB, DiMaio MA, Longacre TA. Intraductal papillary mucinous neoplasms often contain epithelium from multiple subtypes and/or are unclassifiable. Am J Surg Pathol. 2016;40:44-50.